Clinical Trial Update: Study Evaluating the Safety and Efficacy of Tigecycline in Hospitalized Patients With cSSSI [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the safety and efficacy of tigecycline for complicated skin and skin-structure infections in hospitalized patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Skin and Skin Structure Infections

Drugs mentioned

• TYGACIL (tigecycline)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Skin Diseases, Infectious | Phase 4 | Status: COMPLETED